practical management of iv daratumumab in mm
Published 4 years ago • 75 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
1:08
subcutaneous daratumumab: combining efficacy, safety & convenience
-
1:03
columba study update: subcutaneous daratumumab in r/r mm
-
7:00
subcutaneous versus intravenous daratumumab administration in patients with relapsed or refracto...
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
4:59
columba: subcutaneous daratumumab vs. iv administration
-
3:08
clinical impact of subq daratumumab for multiple myeloma
-
14:28
all about darzalex (daratumumab) #myeloma
-
12:57
darzalex faspro® (daratumumab and hyaluronidase-fihj) mechanism of action for multiple myeloma
-
7:02
proteosome inhibitors mechanism of action. pharmacology. bortezomib, ixazomib. myeloma treatment.
-
3:48
subcutaneous daratumumab in r/r myeloma: the columba trial
-
4:27
exciting subcutaneous formulation approval in mm
-
7:45
extrapolating from clinical trials: daratumumab in mm
-
5:20
phase 3 study of sc vs iv daratumumab in patients with relapsed or refractory multiple myeloma
-
5:00
subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma
-
2:40
first in class targeted drug daratumumab shows promise in mm
-
12:21
elotuzumab and daratumumab in multiple myeloma
-
0:49
dr. martin on subcutaneous administration of daratumumab in multiple myeloma
-
13:43
darzalex® iv (daratumumab) mechanism of action for multiple myeloma
-
42:41
phase i study of venetoclax plus daratumumab and dexamethasone, with or without bortezomib...
-
1:05
dr. harrison on subcutaneous daratumumab and isatuximab in myeloma
-
5:53
daratumumab revolutionizing how myeloma is treated